Tag: pharmaceuticals
-
Covid-19 Vaccines, Therapies – 10 August 2020
Seven new vaccine projects got underway last week, raising the total to 164, with six more vaccines reaching clinical trials now totaling 41.
-
Grant Funds Placenta Stem Cell Trial Sites for Covid-19
A clinical trial testing stem cells from human placentas as a treatment for Covid-19 infections is expanding to three more sites in California.
-
Start-Up to Engineer T-Cells for Autoimmune Diseases
GentiBio Inc., a new enterprise in Boston, is starting work on creating engineered T-cells from the immune system to treat autoimmune diseases.
-
NIH Begins Covid-19 Antibody Trials
National Institutes of Health is beginning clinical trials of experimental antibody therapies to treat Covid-19 infections in people with symptoms ranging from mild to severe.
-
New Allergy Biotech Launches, Raises $10M
A new company developing treatments to relieve allergic reactions with reprogrammed antibodies began work and is raising $10 million in its first venture funding round.
-
Trial Set for Covid-19 Antibodies in Long-Term Care
Two companies and NIH are beginning a clinical trial of synthetic antibodies to both treat and prevent Covid-19 infections among people in long-term care.
-
Covid-19 Vaccines, Therapies – 3 August 2020
The numbers of vaccine candidates in development and clinical trials show modest but steady growth, now up to 157 and 35 respectively.
-
Two Covid-19 Vaccines Show Preclinical Immune Responses
Two candidate vaccines to prevent Covid-19 infections show they generate immune protections in lab monkeys, with one vaccine for 13 weeks.
-
Trial Underway for Seasonal Flu Antibody Therapy
A participant in an early-stage clinical trial received the first dose of an experimental synthetic antibody produced in cattle to treat seasonal influenza.
-
Neuro Disease Start-Up Raises $73M in Early Funds
A company developing new therapies for neurodegenerative diseases officially began operations, staked to $73 million raised in its first venture round.